Skip to main content
. 2018 Jan 16;15(3):3719–3725. doi: 10.3892/ol.2018.7806

Figure 1.

Figure 1.

High expression level of RRM2 in cervical cancer patients is associoated with a poor prognosis. (A) Reverse transcription-polymerase chain reaction analysis results of RRM2 in 38 patients with cervical cancer. (B) RRM2 expression was significantly higher in cervical cancer tissues compared with that in the paracarcinoma tissues. (C) Representative images of RRM2 immunohistochemical staining in cervical cancer tissues (right) and paracarcinoma tissues (left). RRM2, ribonucleotide reductase subunit M2.